WHG
PVLA

Westwood Holdings Group’s Palvella Therapeutics PVLA Stock Holding History

Westwood Holdings Group’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-138
Closed -$23K – 464
2020
Q3 		$23K Hold
138
– – ﹤0.01% 404
2020
Q2 		$34K Hold
138
– – ﹤0.01% 398
2020
Q1 		$25K Hold
138
– – ﹤0.01% 401
2019
Q4 		$40K Buy
+138
New +$38.3K ﹤0.01% 503

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westwood Holdings Group's PVLA Position: Q4 2020 in Review

Westwood Holdings Group sold out of Palvella Therapeutics (PVLA) in Q4 2020, closing a stake of 138 shares — an estimated $23K sold.

Westwood Holdings Group first reported a position in PVLA in Q4 2019 and held it in 4 quarters. The position peaked at $40K in Q4 2019. 82 funds tracked by Wall St. Rank hold PVLA as of Q4 2020.

  • Westwood Holdings Group reported no remaining Palvella Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Westwood Holdings Group sold 138 Palvella Therapeutics shares in Q4 2020, an estimated $23K.
  • Westwood Holdings Group first reported a position in Palvella Therapeutics in Q4 2019 and held it in 4 quarters.
  • Westwood Holdings Group's Palvella Therapeutics position peaked at $40K in Q4 2019.
  • 82 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2020.

Based on Westwood Holdings Group's 13F filing for Q4 2020, filed 12 Feb 2021.